Skip to main content

Nexviazyme Prices, Coupons and Patient Assistance Programs

Nexviazyme (avalglucosidase alfa) is a member of the lysosomal enzymes drug class and is commonly used for Pompe Disease.

The cost for Nexviazyme intravenous injection ngpt 100 mg is around $1,962 for a supply of 1 injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Nexviazyme prices

Intravenous Injection

Quantity Per unit Price
1 $1,962.46 $1,962.46

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Nexviazyme Coupons, Copay Cards and Rebates

Nexviazyme offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Nexviazyme CareConnectPSS Copay Assistance Program

Eligible commercially insured patients may have 100% of eligible out-of-pocket drug costs covered up to the program maximum each calendar year when enrolled in the program; for additional information contact the program at 800-745-4447, option 3.

Applies to:
Nexviazyme
Number of uses:
Per prescription per calendar year

Form more information phone: 800-745-4447 or Visit website

Nexviazyme QuickStart Program

Eligible commercially insured patients may be provided up to 4 infusions at no charge if they are experiencing a delay in insurance coverage; for additional information contact the program at 800-745-4447, option 3.

Applies to:
Nexviazyme
Number of uses:
Temporary Assistance

Form more information phone: 800-745-4447 or Visit website

Nexviazyme CareConnectPSS Interim Access Program

Eligible commercially insured patients may receive medication at no cost for up to 6 months if they are experiencing insurance coverage lapses or delays; patient must already be undergoing treatment; for additional information contact the program at 800-745-4447, option 3.

Applies to:
Nexviazyme
Number of uses:
Temporary Assistance

Form more information phone: 800-745-4447 or Visit website

Patient Assistance & Copay Programs for Nexviazyme

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Nexviazyme (avalglucosidase alfa-ngpt) Injection; IV infusion

More information please phone: 866-316-7263 Visit Website

Provider: CareConnect Personalized Support Services (PSS)

Eligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Education and support services are available; Contact program for details. CareConnectPSS is designed to support each patient's unique journey to help them overcome challenges related to living with a rare disease (ASMD, Fabry Disease, Gaucher Disease, MPS 1 and Pompe Disease).
Applicable drugs:
  • Nexviazyme (avalglucosidase alfa-ngpt) Injection; IV infusion

More information please phone: 800-745-4447 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.